Problem: En AI baserad mjukvara för cancerdiagnostik utvecklades, men kraven från IVDR och FDA skapade hög komplexitet kring validering, dokumentation och regulatorisk strategi. Samtidigt saknades anpassade processer för säker och spårbar AI utveckling.
Lösning: Vi etablerade standardanpassade utvecklingsprocesser för AI och ML, samt tog fram en regulatorisk strategi för både CE märkning och FDA. Arbetet inkluderade uppdatering av teknisk dokumentation och initiering av tidig dialog med FDA genom Pre Submission.
Resultat: En regulatoriskt förankrad utveckling möjliggjorde snabbare väg mot marknadsgodkännande i flera regioner. Kunden fick en robust grund för validering, stärkt kvalitet i dokumentationen och ökad trygghet i dialogen med myndigheter.
Yes, we have consultants with experience in technical documentation, regulatory requirements, quality assurance, and medical devices in various risk classes. Requirements often vary depending on product phase, regulatory requirements, and internal resources, and we’d be happy to help you find the right support based on your situation. Please feel free to contact us to discuss your current needs and the expertise we can offer.
We help organizations structure, develop, and maintain technical documentation in accordance with applicable regulatory requirements. Our consultants provide support throughout the entire product lifecycle, from classification and development to revisions, interactions with regulatory authorities, and aftermarket activities.
We take a pragmatic approach and tailor the documentation to the product’s risk class, regulatory requirements, and the organization’s needs. Our goal is to create clear, complete, and auditable documentation that works in practice and remains sustainable over time.
Yes, we offer support in labeling, IFU, and post-market documentation , and related regulatory requirements. We help companies ensure that their documentation and labeling are up to date, traceable, and tailored to relevant markets and regulations.
Yes, we support organizations in their transition from previous regulations to the MDR and IVDR, including gap analyses, remediationefforts, and updating technical documentation. The focus is on creating sustainable structures that work in the long term and stand up to scrutiny.
Absolutely. We help organizations handle inquiries, feedback, and requests for additional information from notified bodies and the FDA, as well as prepare documentation for audits, submissions, and regulatory reviews. Our consultants have experience in both operational and strategic regulatory work.
We specialize in technical documentation within both European and global regulatory frameworks, including the MDR, IVDR, and FDA. Our consultants have experience tailoring documentation structures and regulatory strategies based on the product, risk class, and market requirements.